e20016Background: With the emergence of immunotherapy, genomics, and precision medicine, the future of multiple myeloma (MM) treatment is rapidly evolving. We reviewed the efficacy of (non-FDA appr... Click to show full abstract
e20016Background: With the emergence of immunotherapy, genomics, and precision medicine, the future of multiple myeloma (MM) treatment is rapidly evolving. We reviewed the efficacy of (non-FDA appr...
               
Click one of the above tabs to view related content.